Bcl-2-IN-5

• UNSPSC Description:

  Bcl-2-IN-5 is a BCL-2 inhibitor with IC50s of 0.12 nM, 0.14 nM and 0.22 nM for Bcl-2 wild type, Bcl-2 D103Y and Bcl-2 G101V, respectively. Bcl-2-IN-5 inhibits the cell growth with IC50 values of 0.2 nM and 0.44 nM for Bcl 2-G101V knock-in RS4; 11 and RS4; 11 cells, respectively (WO2021208963A1; Example 155)[1].

• Target Antigen:

  Bcl-2 Family

• Type:

  Reference compound

• Related Pathways:

  Apoptosis

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/bcl-2-in-5.html

• Solubility:

  10 mM in DMSO

• Smiles:

  COC(C=C1)=CC=C1CN(CC2)C[C@](C3=C(C=CC=C3)C(C)C)([H])N2C(C4)CC4(C5)CN5C6=CC(OC7=CN=C(NC=C8F)C8=C7)=C(C(NS(=O)(C9=CC([N+]([O-])=O)=C(C=C9)NC[C@@H]%10CC[C@@](O)(CC%10)C)=O)=O)C=C6

• Molecular Weight:

  1015.20

• References & Citations:

  [1]Hai Xue, et al. Bcl-2 inhibitor. WO2021208963A1.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2728752-20-1